GlassScriptPhysician profile
Soseh Markarian
NPI 1063131456
$2,748.20
in general payments reported to CMS, 2019-2025
17 companies · $1,754 in 2025
The $1,754 reported for 2025 was more than what 96% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $411 · 2024: $583 · 2025: $1,754.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,748.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,748.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $553.41 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $362.65 | 2023-2025 | Cequa |
| Bausch & Lomb Americas INC. | $316.45 | 2023-2025 | Miebo, Vyzulta, Xiidra |
| Alcon Vision LLC | $262.05 | 2024-2025 | Tryptyr, Eysuvis, Rocklatan |
| Ocular Therapeutix, INC. | $242.75 | 2025 | Dextenza |
| Glaukos Corporation | $201.04 | 2023-2025 | Ce-Marked Kxla System, Idosetr |
| Oyster Point Pharma, INC. | $193.57 | 2023-2025 | Tyrvaya, Ryzumvi |
| Dompe US, INC. | $154.10 | 2024-2025 | Oxervate |
| Harrow Eye, LLC | $123.75 | 2025 | Vevye |
| Nova Eye, INC. | $119.82 | 2025 | |
| Mallinckrodt Hospital Products INC. | $56.43 | 2024 | Acthar |
| Johnson & Johnson Surgical Vision, INC. | $51.63 | 2023-2024 | Lipiflow System Activator (Disposable), Tecnis Simplicity |
| Ge Healthcare | $25.43 | 2025 | |
| Tearlab Corp | $23.42 | 2024 | Scoutpro Osmolarity System |
| Biotissue Holdings INC. | $23.24 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $19.96 | 2024 | Iyuzeh |
| Rxsight INC | $18.50 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Soseh Markarian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.